2 Oct 2026Q-Line Biotech Ltd submits scrutinizer's report for 16th AGM held on 30 Sep 2026Record Date
2 Oct 2026Q-Line Biotech Ltd submits scrutinizer's report and voting results for 16th AGM held on 30 Sep 2026Record Date
1 Oct 2026Q-Line Biotech Ltd AGM outcome on 30 Sep 2026Record Date
12 Sept 2026Q-Line Biotech Ltd dispatch of letter to shareholders with bounced emails for AGM notice and annual report access for FY26Record Date
9 Sept 2026Q-Line Biotech Ltd board meeting outcome on 05 Sep 2026 approving AGM notice and director re-appointmentsKMP
9 Sept 2026Q-Line Biotech Ltd issues corrigendum to 07 Sep 2026 intimations correcting typographical error in AGM number from 37 to 16 in subject lines.Record Date
9 Sept 2026Q-Line Biotech Ltd AGM scheduled on 30 Sep 2026Record Date
8 Sept 2026Q-Line Biotech Ltd AGM scheduled on 30 Sep 2026Record Date
3 Sept 2026Q-Line Biotech Ltd enters amended license agreement with Boule Medical AB reducing royalty by 25% effective July 2026MOU
24 Aug 2026Q-Line Biotech Ltd credit rating assigned: CARE A- (Long-Term) and CARE A2+ (Short-Term) by CARE Ratings on 22 Aug 2026Credit Ratings
